Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same

US10239902B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10239902-B2
Application numberUS-201715606628-A
CountryUS
Kind codeB2
Filing dateMay 26, 2017
Priority dateNov 27, 2014
Publication dateMar 26, 2019
Grant dateMar 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a stable peptide-conjugated, ascorbic acid derivative, a method for preparing the same, and a cosmetic composition comprising the same as an active ingredient. The stable peptide-conjugated ascorbic acid derivative of the present invention has both the effect of whitening the skin by inhibiting melanin production and the effect of reducing skin wrinkles by activating collagen production, and may be used in a cosmetic composition.

First claim

Opening claim text (preview).

The invention claimed is: 1. A peptide-conjugated ascorbic acid derivative represented by the following formula I or a cosmetically acceptable salt thereof: wherein represents a peptide in which the same or different amino acid residues selected from among natural or non-natural amino acid residues are bonded by amide bonds; R 1 represents side chains of the amino acid residues; X is hydrogen or carbonyl (C═O); R 2 is null when X is hydrogen, or R 2 is palmityl, lauryl or stearyl when X is carbonyl; and n is an integer ranging from 2 to 5. 2. The peptide-conjugated ascorbic acid derivative or cosmetically acceptable salt thereof according to claim 1 , wherein represents a peptide in which the same or different amino acid residues selected from among valine, lysine, glycine, arginine, aspartic acid, threonine and serine are bonded by amide bonds. 3. The peptide-conjugated ascorbic acid derivative or cosmetically acceptable salt thereof according to claim 2 , wherein n is an integer ranging from 3 to 5. 4. The peptide-conjugated ascorbic acid derivative or cosmetically acceptable salt thereof according to claim 1 , wherein is selected from among lysine-valine-lysine and arginine-glycine-aspartic acid. 5. The peptide-conjugated ascorbic acid derivative or cosmetically acceptable salt thereof according to claim 4 , which is selected from among the following compounds: (6S,9S,12S)-6,12-bis(4-aminobutyl)-9-isopropyl-5,8,11,14-tetraoxo-4,7,10,13-tetraazanonacosyl (5-((S)-1,2-dihydroxyethyl)-4-hydroxy-2-oxo-2,5-dihydrofuran-3-yl) hydrogen phosphate (I-1); and (3S)-3-(2-((S)-2-amino-5-((diaminomethylene)amino)pentanamido)acetamido)-4-((3-((((5-((S)-1,2-dihydroxyethyl)-4-hydroxy-2-oxo-2,5-dihydrofuran-3-yl)oxy)(hydroxy)phosphoryl)oxy)propyl)amino)-4-oxobutanoic acid (I-2). 6. A method for preparing a peptide-conjugated ascorbic acid derivative represented by formula I, the method comprising a step of subjecting a compound of the following formula II to a condensation reaction with a compound of the following formula IV, and then subjecting a product of the condensation reaction to a deprotection reaction if a protecting group is present in the product: wherein represents a peptide in which the same or different amino acid residues selected from among natural or non-natural amino acid residues are bonded by amide bonds; R 1 represents side chains of the amino acid residues; R 1 ′ is equal to R 1 or is R 1 in which amino group or carboxyl group is protected; X is hydrogen or carbonyl (C═O); R 2 is null when X is hydrogen, or R 2 is palmityl, lauryl or stearyl when X is carbonyl; n is an integer ranging from 2 to 5. 7. A cosmetic composition, comprising (i) a peptide-conjugated ascorbic acid derivative represented by the following formula I or a cosmetically acceptable salt thereof and (ii) cosmetically acceptable base: wherein represents a peptide in which the same or different amino acid residues selected from among natural or non-natural amino acid residues are bonded by amide bonds; R 1 represents side chains of the amino acid residues; X is hydrogen or carbonyl (C═O); R 2 is null when X is hydrogen, or R 2 is palmityl, lauryl or stearyl when X is carbonyl; and n is an integer ranging from 2 to 5. 8. The cosmetic composition of claim 7 , which is for use of reducing skin wrinkles and whitening the skin. 9. The cosmetic composition of claim 7 , wherein the compound of formula I is comprised in an amount of 0.0001 to 2 wt % based on the total weight of the cosmetic composition.

Assignees

Inventors

Classifications

  • Anti-ageing preparations · CPC title

  • A61K9/0014Primary

    Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title

  • the first amino acid being Arg · CPC title

  • the oxygen atom being part of a five-membered ring · CPC title

  • Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10239902B2 cover?
The present invention provides a stable peptide-conjugated, ascorbic acid derivative, a method for preparing the same, and a cosmetic composition comprising the same as an active ingredient. The stable peptide-conjugated ascorbic acid derivative of the present invention has both the effect of whitening the skin by inhibiting melanin production and the effect of reducing skin wrinkles by activat…
Who is the assignee on this patent?
Celltrion Inc
What technology area does this patent fall under?
Primary CPC classification A61K9/0014. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).